✦ LIBER ✦

HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH CHRONIC HEPATITIS C. THE IMPACT OF ANTIVIRAL THERAPY

✍ Scribed by Vasilios Papastergiou; Lamprini Skorda; Phillipos Lisgos; Mihail Hletsos; Ioannis Ketikoglou; Christos Zamanis; Stylianos Karatapanis

Book ID: 117646378
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 65 KB
Volume: 22
Category: Article
ISSN: 0953-6205
DOI: 10.1016/s0953-6205(11)60190-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Health-Related Quality of Life and Depre

✍ Juan Fernando Gallegos-Orozco; Ana Paula Fuentes; Juan Gerardo Argueta; Christia 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 93 KB

Health-related quality of life in patien

✍ Silvia Bondini; Jillian Kallman; Amy Dan; Zahra Younoszai; Lolita Ramsey; Fatema 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 93 KB

Health-related quality of life in patien

✍ Herbert L. Bonkovsky; Kristin K. Snow; Peter F. Malet; Carla Back-Madruga; Rober 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 181 KB

Health-related quality of life in chroni

✍ Siew Chin Ong; Belinda Mak; Myat Oo Aung; Shu-Chuen Li; Seng-Gee Lim 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 136 KB 👁 1 views

The relationship between stages of chronic hepatitis B liver disease and health-related quality of life (HRQoL) is an important aspect of the overall management of hepatitis B virus (HBV) infection, yet is not well characterized. Consequently we sought to examine HRQoL in HBV patients, stratified by

Reduction of health-related quality of l

Reduction of health-related quality of life in chronic hepatitis C and improvement with interferon therapy

✍ Herbert L. Bonkovsky; J. Michael Woolley 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 163 KB 👁 1 views

Health-related quality of life in chroni

✍ John E. Ware Jr; Martha S. Bayliss; Michael Mannocchia; Gary L. Davis 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB 👁 1 views

Hepatitis C infects nearly 4 million Americans. Most have chronic hepatitis C (CHC), which progresses to cirrhosis in about 20% of patients. Interferon treatment leads to transient responses in about 40% of patients and apparent eradication of infection in 7% to 40% of patients. In this report, we d